Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Shmuel Yaccoby

Concepts (332)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
63
2023
2929
5.050
 Why?
Osteoclasts
17
2015
425
2.610
 Why?
Bone Diseases
7
2014
99
2.360
 Why?
Osteoblasts
13
2012
450
1.520
 Why?
Gene Expression Regulation, Neoplastic
12
2018
828
1.340
 Why?
Osteolysis
6
2013
75
1.290
 Why?
Boronic Acids
12
2013
182
1.250
 Why?
Neoplasm Proteins
6
2018
322
1.240
 Why?
Coculture Techniques
12
2015
146
1.230
 Why?
Mice, SCID
17
2015
175
1.050
 Why?
Bone Marrow Cells
5
2015
191
1.030
 Why?
Cell Differentiation
14
2018
651
0.990
 Why?
Bone and Bones
9
2014
469
0.980
 Why?
Pyrazines
11
2013
187
0.930
 Why?
Bone Marrow
8
2018
362
0.880
 Why?
Cell Proliferation
11
2023
1007
0.830
 Why?
Mice
26
2015
5739
0.790
 Why?
Cell Communication
3
2015
69
0.780
 Why?
Intercellular Signaling Peptides and Proteins
4
2010
104
0.730
 Why?
Osteogenesis
5
2012
352
0.720
 Why?
Bone Resorption
4
2011
304
0.690
 Why?
Adipocytes
2
2018
121
0.660
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.650
 Why?
Animals
29
2016
13187
0.630
 Why?
Proteoglycans
4
2008
80
0.630
 Why?
Bone Neoplasms
2
2011
179
0.620
 Why?
Gene Expression
3
2018
609
0.600
 Why?
Humans
62
2023
49974
0.580
 Why?
Antineoplastic Agents
9
2015
1171
0.570
 Why?
Cell Movement
4
2013
247
0.570
 Why?
Neoplastic Stem Cells
1
2017
103
0.550
 Why?
Cell Survival
9
2015
600
0.540
 Why?
Protease Inhibitors
4
2010
58
0.540
 Why?
Tumor Microenvironment
2
2015
212
0.540
 Why?
Cytokines
3
2015
612
0.510
 Why?
Cysteine-Rich Protein 61
1
2014
3
0.490
 Why?
Plasma Cells
6
2009
223
0.460
 Why?
Nicotinamide Phosphoribosyltransferase
1
2013
5
0.440
 Why?
Angiogenesis Inhibitors
3
2010
187
0.430
 Why?
Membrane Glycoproteins
5
2009
240
0.430
 Why?
Protein-Tyrosine Kinases
1
2013
95
0.420
 Why?
Mesenchymal Stem Cell Transplantation
1
2012
18
0.410
 Why?
Thalidomide
6
2016
377
0.410
 Why?
Parathyroid Hormone
4
2010
147
0.390
 Why?
Gene Expression Profiling
7
2023
1032
0.390
 Why?
Up-Regulation
3
2013
452
0.390
 Why?
Wnt Proteins
2
2010
100
0.390
 Why?
Rabbits
5
2013
370
0.360
 Why?
Signal Transduction
6
2013
1618
0.350
 Why?
Receptor, EphB4
1
2009
5
0.340
 Why?
Ephrin-B2
1
2009
5
0.340
 Why?
Placenta
1
2011
132
0.340
 Why?
Fenretinide
1
2009
5
0.340
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2009
6
0.340
 Why?
Disease Models, Animal
7
2016
1455
0.340
 Why?
Dipeptides
1
2009
21
0.330
 Why?
Models, Biological
4
2010
727
0.330
 Why?
Cell Line, Tumor
9
2015
1403
0.330
 Why?
Cell Adhesion Molecules
1
2009
88
0.330
 Why?
Antineoplastic Combined Chemotherapy Protocols
8
2016
989
0.320
 Why?
Bone Development
1
2009
65
0.310
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 13
1
2007
3
0.310
 Why?
Transmembrane Activator and CAML Interactor Protein
1
2007
6
0.310
 Why?
Extracellular Matrix Proteins
1
2008
69
0.310
 Why?
Apoptosis
8
2012
1101
0.300
 Why?
Disease Progression
6
2014
825
0.300
 Why?
Bone Remodeling
4
2012
150
0.290
 Why?
Recombinant Fusion Proteins
1
2007
181
0.290
 Why?
Neoplasm Recurrence, Local
3
2023
614
0.270
 Why?
Antibodies
1
2006
154
0.270
 Why?
Immunohistochemistry
5
2015
973
0.270
 Why?
Tumor Cells, Cultured
7
2013
465
0.260
 Why?
Serine Endopeptidases
1
2006
52
0.260
 Why?
Transplantation, Heterologous
5
2009
74
0.260
 Why?
RNA, Small Interfering
4
2013
215
0.260
 Why?
Antigens, Neoplasm
1
2006
151
0.250
 Why?
Prognosis
10
2018
1942
0.250
 Why?
Melphalan
2
2016
174
0.250
 Why?
Severe Combined Immunodeficiency
1
2005
12
0.250
 Why?
Neovascularization, Pathologic
4
2009
161
0.250
 Why?
Alkaline Phosphatase
6
2017
94
0.240
 Why?
NF-kappa B
4
2013
314
0.240
 Why?
Hematopoietic Stem Cells
3
2012
184
0.230
 Why?
Cell Division
5
2004
292
0.220
 Why?
Bone Density
3
2010
379
0.220
 Why?
Killer Cells, Natural
2
2015
95
0.220
 Why?
Positron-Emission Tomography
2
2017
295
0.220
 Why?
Translocation, Genetic
2
2021
264
0.210
 Why?
Stromal Cells
1
2003
72
0.210
 Why?
Transcription Factors
2
2023
561
0.210
 Why?
Immunophenotyping
2
2015
109
0.200
 Why?
Immunotherapy, Adoptive
2
2015
156
0.200
 Why?
Cell Line
2
2015
1000
0.200
 Why?
T-Lymphocytes
2
2015
338
0.200
 Why?
Epigenomics
1
2021
67
0.200
 Why?
Bone Transplantation
4
2010
47
0.190
 Why?
Decorin
2
2012
7
0.190
 Why?
Antibodies, Monoclonal
3
2016
459
0.180
 Why?
Drug Resistance, Neoplasm
2
2015
308
0.170
 Why?
Female
17
2018
26472
0.170
 Why?
Cells, Cultured
4
2013
1573
0.170
 Why?
Syndecan-1
4
2007
72
0.170
 Why?
Genes, myc
1
2019
40
0.170
 Why?
Risk Factors
5
2018
3613
0.150
 Why?
Mice, Transgenic
4
2007
555
0.150
 Why?
Cyclin-Dependent Kinases
2
2015
28
0.150
 Why?
Oligonucleotide Array Sequence Analysis
3
2009
411
0.150
 Why?
Diffusion Magnetic Resonance Imaging
1
2018
123
0.150
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2018
103
0.150
 Why?
Hexokinase
1
2017
17
0.150
 Why?
Tumor Suppressor Protein p53
2
2017
202
0.150
 Why?
Chromosomes, Human, Pair 17
1
2017
36
0.140
 Why?
Chromosome Aberrations
3
2016
297
0.140
 Why?
Calcification, Physiologic
1
2017
41
0.140
 Why?
Proteasome Inhibitors
2
2016
104
0.140
 Why?
Pelvis
1
2017
68
0.140
 Why?
Stem Cells
2
2009
171
0.140
 Why?
Chromosome Deletion
1
2017
140
0.140
 Why?
Biopsy
2
2018
584
0.140
 Why?
Neoplasm, Residual
1
2017
165
0.140
 Why?
Pyridinium Compounds
1
2015
19
0.130
 Why?
Male
14
2018
25241
0.130
 Why?
Neoplasms, Experimental
2
2007
114
0.130
 Why?
Base Sequence
2
2008
643
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.130
 Why?
Fluorodeoxyglucose F18
1
2017
192
0.130
 Why?
Endothelial Cells
2
2009
269
0.130
 Why?
Homologous Recombination
1
2015
40
0.130
 Why?
Benzimidazoles
1
2015
48
0.130
 Why?
Xenograft Model Antitumor Assays
3
2015
211
0.130
 Why?
Peptide Nucleic Acids
1
2015
17
0.130
 Why?
Rad51 Recombinase
1
2015
22
0.130
 Why?
Genes, Neoplasm
1
2015
30
0.130
 Why?
Bromodeoxyuridine
2
2005
19
0.130
 Why?
Immunologic Factors
1
2016
114
0.120
 Why?
Flow Cytometry
5
2012
476
0.120
 Why?
Genomic Instability
1
2015
92
0.120
 Why?
Diphosphonates
2
2008
90
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2006
595
0.120
 Why?
Antigens, CD
1
2015
219
0.120
 Why?
Asymptomatic Diseases
1
2014
36
0.120
 Why?
Proteome
1
2015
173
0.120
 Why?
Immunotherapy
1
2016
238
0.110
 Why?
Time Factors
6
2017
2903
0.110
 Why?
Interleukin-6
2
2005
264
0.110
 Why?
Nicotinamide Mononucleotide
1
2013
3
0.110
 Why?
Acrylamides
1
2013
6
0.110
 Why?
Receptors, CXCR4
1
2013
28
0.110
 Why?
Niacinamide
1
2013
22
0.110
 Why?
Poly(ADP-ribose) Polymerases
1
2013
30
0.110
 Why?
Amides
1
2013
34
0.110
 Why?
NAD
1
2013
43
0.110
 Why?
Enzyme Induction
1
2013
80
0.110
 Why?
Sirtuin 1
1
2013
28
0.110
 Why?
Chemokine CXCL12
1
2013
32
0.110
 Why?
Nitriles
1
2013
54
0.110
 Why?
Oligopeptides
1
2013
89
0.110
 Why?
Recurrence
2
2012
652
0.110
 Why?
beta Catenin
1
2013
102
0.110
 Why?
Tumor Burden
2
2010
132
0.110
 Why?
Gene Knockdown Techniques
1
2013
106
0.110
 Why?
Enzyme Inhibitors
2
2013
391
0.110
 Why?
Leukemia
1
2013
65
0.110
 Why?
Magnetic Resonance Imaging
2
2012
1537
0.110
 Why?
Proteomics
1
2015
329
0.110
 Why?
Myelodysplastic Syndromes
1
2013
81
0.110
 Why?
Injections, Intravenous
1
2012
140
0.100
 Why?
Proto-Oncogene Proteins c-jun
2
2009
75
0.100
 Why?
Piperidines
1
2013
98
0.100
 Why?
Cytotoxicity, Immunologic
1
2012
54
0.100
 Why?
Remission Induction
1
2012
207
0.100
 Why?
Syndecans
3
2006
34
0.100
 Why?
Anti-Inflammatory Agents
1
2012
161
0.090
 Why?
Aged
8
2017
9310
0.090
 Why?
Lymph Nodes
1
2012
260
0.090
 Why?
beta 2-Microglobulin
2
2007
38
0.090
 Why?
JNK Mitogen-Activated Protein Kinases
2
2007
72
0.090
 Why?
Middle Aged
9
2018
12069
0.090
 Why?
Disease-Free Survival
3
2018
454
0.090
 Why?
Early Growth Response Protein 1
1
2009
35
0.090
 Why?
Myocardium
1
2012
436
0.090
 Why?
Dexamethasone
3
2007
430
0.080
 Why?
Sphingosine
1
2009
26
0.080
 Why?
Lysophospholipids
1
2009
34
0.080
 Why?
Organoids
1
2009
39
0.080
 Why?
Drug Screening Assays, Antitumor
1
2009
136
0.080
 Why?
Prospective Studies
5
2016
2364
0.080
 Why?
Caspases
1
2009
104
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
96
0.080
 Why?
Leukocytes, Mononuclear
1
2009
116
0.080
 Why?
Enzyme Activation
1
2009
276
0.080
 Why?
Glucuronidase
2
2007
46
0.080
 Why?
Lentivirus
1
2008
16
0.080
 Why?
Immunoglobulin Light Chains
1
2009
81
0.080
 Why?
Wnt3 Protein
1
2008
7
0.080
 Why?
Ellipticines
1
2008
2
0.080
 Why?
Wnt3A Protein
1
2008
11
0.080
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.080
 Why?
B-Cell Activating Factor
1
2007
3
0.080
 Why?
Bone Density Conservation Agents
1
2009
77
0.080
 Why?
Precancerous Conditions
1
2008
83
0.080
 Why?
Cytological Techniques
1
2007
14
0.080
 Why?
Diploidy
1
2007
26
0.080
 Why?
Genetic Vectors
1
2008
125
0.070
 Why?
RNA Interference
1
2008
179
0.070
 Why?
Karyotyping
1
2007
83
0.070
 Why?
Phosphorylation
1
2009
535
0.070
 Why?
RNA, Messenger
2
2008
1105
0.070
 Why?
Heparan Sulfate Proteoglycans
1
2007
11
0.070
 Why?
Hematopoietic Stem Cell Transplantation
1
2012
565
0.070
 Why?
Neoplasm Staging
2
2007
740
0.070
 Why?
Reactive Oxygen Species
1
2009
408
0.070
 Why?
Mice, Inbred C57BL
1
2012
1816
0.070
 Why?
Phenotype
2
2009
729
0.070
 Why?
Immunosuppressive Agents
1
2008
221
0.070
 Why?
Models, Animal
1
2007
233
0.070
 Why?
Carrier Proteins
2
2008
304
0.070
 Why?
Risk Assessment
3
2018
1259
0.070
 Why?
Gelatinases
1
2006
32
0.070
 Why?
Endopeptidases
1
2006
66
0.070
 Why?
Antigens, CD19
1
2005
24
0.070
 Why?
Survival Analysis
2
2018
653
0.070
 Why?
Antigens, CD34
1
2005
66
0.060
 Why?
Fetal Tissue Transplantation
1
2005
10
0.060
 Why?
Hematologic Neoplasms
1
2006
99
0.060
 Why?
Molecular Sequence Data
1
2006
792
0.060
 Why?
Endothelium, Vascular
1
2006
252
0.060
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
30
0.060
 Why?
Annexin A5
1
2004
13
0.060
 Why?
Culture Media, Conditioned
1
2004
48
0.060
 Why?
Phagocytosis
1
2004
48
0.060
 Why?
Clinical Trials as Topic
3
2016
461
0.060
 Why?
Neoplasm Metastasis
1
2004
231
0.060
 Why?
Membrane Proteins
1
2006
341
0.060
 Why?
Polymerase Chain Reaction
1
2005
453
0.060
 Why?
Pregnancy
1
2011
2607
0.060
 Why?
Adult
5
2018
13236
0.050
 Why?
Endothelial Growth Factors
1
2002
9
0.050
 Why?
RANK Ligand
1
2004
179
0.050
 Why?
Vascular Endothelial Growth Factors
1
2002
15
0.050
 Why?
Lymphokines
1
2002
20
0.050
 Why?
Biotransformation
1
2002
86
0.050
 Why?
Oxidative Stress
1
2007
770
0.050
 Why?
Blotting, Western
2
2015
601
0.050
 Why?
Oncogenes
1
2021
57
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2002
201
0.050
 Why?
Combined Modality Therapy
2
2016
637
0.050
 Why?
Imidazoles
1
2002
119
0.050
 Why?
Polycomb Repressive Complex 2
1
2021
47
0.050
 Why?
Chromatin
1
2021
151
0.050
 Why?
Liver Transplantation
1
2002
148
0.050
 Why?
Treatment Outcome
4
2017
5141
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
 Why?
Histones
1
2021
312
0.040
 Why?
Aged, 80 and over
2
2017
3129
0.040
 Why?
Radiography
2
2012
489
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
259
0.040
 Why?
DNA-Binding Proteins
1
2021
427
0.040
 Why?
Tomography, X-Ray Computed
2
2017
1159
0.040
 Why?
False Positive Reactions
1
2017
63
0.040
 Why?
Metaphase
1
2016
44
0.040
 Why?
Liver
1
2002
1115
0.030
 Why?
Indolizines
1
2015
5
0.030
 Why?
Cyclic N-Oxides
1
2015
12
0.030
 Why?
Imaging, Three-Dimensional
1
2017
151
0.030
 Why?
Transcriptome
1
2018
315
0.030
 Why?
Survival Rate
1
2018
894
0.030
 Why?
Drug Synergism
1
2015
150
0.030
 Why?
S Phase
1
2015
19
0.030
 Why?
Genes, BRCA1
1
2015
19
0.030
 Why?
Follow-Up Studies
2
2013
2182
0.030
 Why?
Predictive Value of Tests
2
2007
903
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
244
0.030
 Why?
Transcription, Genetic
1
2015
369
0.030
 Why?
DNA Damage
1
2015
301
0.030
 Why?
Transfection
2
2004
354
0.030
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.030
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.030
 Why?
Interleukin-2
1
2012
72
0.030
 Why?
Acute Disease
1
2013
366
0.030
 Why?
Mice, Inbred NOD
1
2012
96
0.030
 Why?
Immunoenzyme Techniques
1
2012
143
0.030
 Why?
Lymphocyte Activation
1
2012
172
0.020
 Why?
Radiation-Sensitizing Agents
1
2010
53
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2009
20
0.020
 Why?
Incidence
1
2013
1003
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
12
0.020
 Why?
Protein Transport
1
2010
180
0.020
 Why?
Microtubule-Associated Proteins
1
2009
67
0.020
 Why?
Peptides
1
2010
223
0.020
 Why?
CDC2-CDC28 Kinases
1
2008
12
0.020
 Why?
Down-Regulation
1
2009
348
0.020
 Why?
Salvage Therapy
1
2008
139
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2009
225
0.020
 Why?
Protein Binding
1
2009
660
0.020
 Why?
Proteins
1
2010
342
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
47
0.020
 Why?
Phospholipase C gamma
1
2006
4
0.020
 Why?
Cytogenetic Analysis
1
2007
82
0.020
 Why?
Caspase 9
1
2006
15
0.020
 Why?
Chi-Square Distribution
1
2007
280
0.020
 Why?
Cell Cycle
1
2008
231
0.020
 Why?
Multivariate Analysis
1
2008
577
0.020
 Why?
Mitogen-Activated Protein Kinase 3
1
2006
50
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
Osteoprotegerin
1
2006
52
0.020
 Why?
Bone Marrow Transplantation
1
2007
116
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
RNA, Neoplasm
1
2006
44
0.020
 Why?
src-Family Kinases
1
2006
51
0.020
 Why?
Case-Control Studies
1
2009
1131
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2006
157
0.020
 Why?
Mice, Inbred BALB C
1
2006
304
0.020
 Why?
Chromosome Mapping
1
2006
156
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2006
141
0.020
 Why?
Cluster Analysis
1
2006
235
0.020
 Why?
Kaplan-Meier Estimate
1
2007
466
0.020
 Why?
Data Interpretation, Statistical
1
2006
158
0.020
 Why?
Transplantation, Autologous
1
2007
466
0.020
 Why?
Logistic Models
1
2007
888
0.020
 Why?
DNA, Complementary
1
2004
135
0.020
 Why?
Dose-Response Relationship, Drug
1
2007
1376
0.010
 Why?
Young Adult
1
2013
3958
0.010
 Why?
Recombinant Proteins
1
2004
486
0.010
 Why?
Randomized Controlled Trials as Topic
1
2005
549
0.010
 Why?
Solubility
1
2002
69
0.010
 Why?
Leukemia, Plasma Cell
1
2002
33
0.010
 Why?
Protein Structure, Tertiary
1
2002
253
0.010
 Why?
Adolescent
1
2013
6356
0.010
 Why?
Neoplasm Invasiveness
1
2002
267
0.010
 Why?
Retrospective Studies
1
2005
6108
0.010
 Why?
Yaccoby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (332) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department